Concepedia

Author

Simon Cheesman

University College London

Also Known As

S Cheesman, S. Cheesman, Simon Cheesman

40

Publications

282

Citations

9

H-Index

13

Concepts

All Affiliations

University College LondonUniversity College London Hospitals NHS Foundation TrustRoyal London HospitalThe Royal Free HospitalUCL Biomedical Research Centre
SC

About

Simon Cheesman is an author at University College London specializing in health sciences, oncology, and immunodeficiencies.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

28

2

Medicine

1

1

28

3

Immunology

1

1

28

4

Neurology

1

1

28

5

Pathology

1

1

28

Simon Cheesman

×

8

Publications

186

Citations

8

H-Index

YearCitations

Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy

Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham,

British Journal of Haematology

2019

40

Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis

Oliver C. Cohen, Faye Sharpley, Julian D. Gillmore,

British Journal of Haematology

2020

37

Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre <scp>UK</scp> experience

Nicola Maciocia, Andrew Melville, Simon Cheesman,

British Journal of Haematology

2017

30

Treatment of diffuse large B‐cell lymphoma with secondary central nervous system involvement: encouraging efficacy using <scp>CNS</scp>‐penetrating R‐<scp>IDARAM</scp> chemotherapy

Paul Maciocia, Mohsin Badat, Simon Cheesman,

British Journal of Haematology

2015

28

Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura

Matthew Stubbs, Ryan Low, Siobhan McGuckin,

British Journal of Haematology

2019

14

Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis

Oliver Cohen, Maximillian H. Brodermann, Iona J. Blakeney,

Amyloid

2020

14

Introduction of Biosimilar Rituximab: A Hospital Perspective

Simon Cheesman

HemaSphere

2020

12

Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy

Lucy Neave, Daniel P. Gale, Simon Cheesman,

British Journal of Haematology

2019

11

Page 1